Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 12, 2019 - Issue 8
Submit an article Journal homepage
695
Views
10
CrossRef citations to date
0
Altmetric
Review

Role of rivaroxaban in the prevention of atherosclerotic events

Marcelo SanmartínCardiology Department, Hospital Ramón y Cajal, Madrid, SpainCorrespondence[email protected]
View further author information
,
Sergi BellmuntVascular Surgery Department, Hospital General Vall d´Hebron, Barcelona, SpainView further author information
,
Juan Cosín-SalesCardiology Department, Hospital Arnau de Vilanova, Valencia, SpainView further author information
,
Xavier García-MollCardiology Department, Hospital Sant Pau, Barcelona, SpainView further author information
,
Antoni Riera-MestreInternal Medicine Department, Hospital Universitari de Bellvitge-IDIBELL, Universitat de Barcelona, Barcelona, SpainView further author information
,
Manuel Almendro-DeliaCardiology Department, Hospital Virgen Macarena, Sevilla, SpainView further author information
,
José Luis HernándezInternal Medicine Department, Hospital Marqués de Valdecilla-IDIVAL, Universidad de Cantabria, Santander, SpainView further author information
,
Francisco LozanoDepartment of Surgery, Hospital Clinico de Salamanca, Salamanca, SpainView further author information
,
Pilar MazónCardiology Department, Hospital Clinico Universitario de Santiago de Compostela, CIBERCV, Santiago de Compostela, SpainView further author information
&
Carmen Suarez FernándezInternal Medicine Department, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, SpainView further author information
 show all
Pages 771-780 | Received 15 Feb 2019, Accepted 26 Jun 2019, Published online: 09 Jul 2019

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Paulina Gorzelak-Pabis, Marlena Broncel, Katarzyna Wojdan, Adrian Gajewski, Maciej Chalubinski, Mateusz Gawrysiak & Ewelina Wozniak. (2021) Rivaroxaban protects from the oxysterol-induced damage and inflammatory activation of the vascular endothelium. Tissue Barriers 9:4.
Read now
José R. González-Juanatey, Manuel Almendro-Delia, Juan Cosín-Sales, Sergi Bellmunt-Montoya, Juan José Gómez-Doblas, Vincent Riambau, Xavier García-Moll, Javier García-Alegría, José Luis Hernández, Francisco S. Lozano & Carmen Suarez Fernández. (2020) Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition. Expert Review of Clinical Pharmacology 13:7, pages 695-706.
Read now

Articles from other publishers (8)

Andreas Goette, Martin Mollenhauer, Volker Rudolph, Mathias Lamparter, Martin Meier & Michael Böhm. (2023) Pleiotropic effects of NOACs with focus on edoxaban: scientific findings and potential clinical implicationsPleiotrope Effekte von NOAC mit Fokus auf Edoxaban – wissenschaftliche und potenzielle klinische Implikationen. Herzschrittmachertherapie + Elektrophysiologie 34:2, pages 142-152.
Crossref
Nour N. Abedalqader, Abeer M. Rababa’h & Mera Ababneh. (2022) The protective effect of rivaroxaban with or without aspirin on inflammation, oxidative stress, and platelet reactivity in isoproterenol-induced cardiac injury in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 396:2, pages 337-351.
Crossref
Paulina Gorzelak‐Pabiś, Agnieszka Pawlos, Marlena Broncel, Katarzyna Wojdan & Ewelina Woźniak. (2022) Expression of anti and pro‐inflammatory genes in human endothelial cells activated by 25‐hydroxycholesterol: A comparison of rivaroxaban and dabigatran. Clinical and Experimental Pharmacology and Physiology 49:8, pages 805-812.
Crossref
Armond Daci, Lorenzo Da Dalt, Rame Alaj, Shpejtim Shurdhiqi, Burim Neziri, Rrahman Ferizi, Giuseppe Danilo Norata & Shaip Krasniqi. (2020) Rivaroxaban improves vascular response in LPS-induced acute inflammation in experimental models. PLOS ONE 15:12, pages e0240669.
Crossref
Yuji Ikari, Fumie Saito, Takahiko Kiyooka, Masakazu Nagaoka, Manabu Kimura, Takayuki Furuki & Shigemitsu Tanaka. (2020) Switching from Warfarin to rivaroxaban induces sufficiency of vitamin K and reduction of arterial stiffness in patients with atrial fibrillation. Heart and Vessels 35:12, pages 1727-1733.
Crossref
S. G. Kanorskii. (2020) Coronary Artery Disease with a High Risk of Complications: How to Identify Such Patients and Choose Management Tactics?. Rational Pharmacotherapy in Cardiology 16:3, pages 465-473.
Crossref
Dominic Millenaar, Philipp Bachmann, Michael Böhm, Florian Custodis & Stephan H. Schirmer. (2020) Effects of edoxaban and warfarin on vascular remodeling: Atherosclerotic plaque progression and collateral artery growth. Vascular Pharmacology 127, pages 106661.
Crossref
S. G. Kanorskii. (2020) Combined Antithrombotic Therapy in Patients with a Stable Atherosclerotic Cardiovascular Diseases: What Direction did COMPASS Show?. Kardiologiia 60:2, pages 131-141.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.